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Tubular and interstitial renal disease due to immunologic
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It is generally accepted that many types of glomer-
ular diseases are mediated by antibodies, either
through deposition of circulating immune complexes
or due to antiglomerular basement membrane anti-
bodies (anti-GBM disease) [1, 2]. Until recently, how-
ever, little consideration was given to the possibility
that there might be immunologically mediated damage
directly involving renal tubules or interstitial tissue.
However, there is now compelling evidence, derived
from experimental models as well as human disease,
that tubular and interstitial lesions can result from im-
mune complexes or from autoantibodies against tubu-
lar basement membrane constituents (anti-TBM
disease) [2]. Moreover, in contrast with the glomerulus,
it appears that the renal interstitium is an area where
cell-mediated reactions can occur, accounting for some
forms of interstitial nephritis.
We shall describe the experimental models of im-
munologically mediated tubular and interstitial renal
disease (Table 1) as well as evidence concerning the
occurrence and importance of similar lesions in man.
1. Antibody-mediated tubular and interstitial renal
disease. A. Tubular and interstitial immune complex
diseases. 1. Experimental models, a. Autologous im-
mune complex disease. The first descriptions of im-
mune complex deposition involving tubular basement
membranes were in rabbits injected with preparations
of homologous renal tissue in adjuvant, or given re-
peated renal allografts [3—5]. Comparable lesions have
been observed in rats injected with homologous kidney
suspensions in Freund's adjuvant and with pertussis
vaccine [6].
The mechanisms accounting for the deposits were
explored in a study in which rabbits were injected with
a soluble extract of renal cortical tissue largely devoid
of tubular and glomerular basement membrane [5].
After ten injections given every other week, many of
the rabbits developed irregular interstitial fibrosis,
tubular cell damage and thickening or reduplication of
tubular basement membranes. Interstitial infiltrates of
mononuclear cells were also present, but were gener-
ally mild and focal. The glomeruli appeared normal for
several months, after which some rabbits were found
to have mild proliferation of mesangial cells; by this
time the tubular and interstitial lesions were generally
very severe. Some of the rabbits had glucosuria and
aminoaciduria.
Table 1. Immunologically mediated tubular and interstitial renal
diseases
I. Antibody-mediated tubular and interstitial renal diseases
A. Tubular and interstitial immune complex diseases
I. Experimental models
a. Autologous immune complex disease
b. Exogenous immune complex disease
2. Human diseases
B. Antitubular basement membrane antibody disease
(anti-TBM disease)
1. Experimental models
2. Human diseases
C. Cytotoxic damage to tubular cells
I. Experimental model
II. Cell-mediated tubular and interstitial renal diseases
A. Autologous antigens
1. Experimental model
2. Human diseases
B. Exogenous antigens
I. Experimental model
2. Human diseases
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The immunofluorescence findings were impressive.
Granular deposits of IgG and C3 were seen along the
basement membranes of proximal convoluted tubules;
in some animals the deposits were scanty, whereas in
others they were widespread (Fig. 1). In most rabbits
the glomeruli showed no staining, but in the animals
that developed proliferative glomerular lesions late in
the experiment, irregular deposits of immunoglobulins
and complement were found within mesangial regions,
indicating an immune complex glomerular disease.
The pattern of accumulation of immunoglobulins
suggested to us that they represented deposits of im-
mune complexes, rather than autoantibodies directed
against the tubular basement membrane, as had been
proposed by Unanue, Dixon and Feldman [3]. In sup-
port of our interpretation was the absence of antibodies
that reacted with normal renal tubular basement
membranes, either in the circulation or in eluates ob-
tained from kidney tissue. There were, however, anti-
bodies, demonstrable by immunofluorescence, directed
against antigens normally present in the cytoplasm of
proximal tubular cells. We therefore suggested that the
deposits along the basement membranes resulted from
the combination of circulating autoantibodies with
autologous antigens as they moved out of tubular cells.
b. Exogenous immune complex disease. Recently,
Brentjens et al [7] have described the development of
deposits of immune complexes in several extraglomer-
ular sites in the kidneys of rabbits given multiple
daily injections of high doses of bovine serum albumin
(BSA) for prolonged periods. Immunofluorescence
showed granular deposits of BSA, IgG, 1gM and C3
along tubular basement membranes and in what
appeared to be walls of peritubular capillaries, as well
as in Bowman's capsule (Figs. 2 through 5). The
precise location of the deposits was studied by electron
microscopy. Electron-dense material was found along
either side of or within tubular basement membranes
(Figs. 6 through 8) or peritubular (Figs. 7, 8 and 8
inset) capillary basement membranes, as well as within
the interstitium and in association with Bowman's
capsule. In addition to glomerular lesions, histologic
examination showed interstitial fibrosis and accumula-
tion of mononuclear cells and neutrophils (Fig. 5),
tubular cell damage and tubular basement membrane
thickening and reduplication. Some of the rabbits
developed renal glucosuria, indicating tubular dys-
function.
These tubular and interstitial abnormalities had not
been commented upon in earlier studies of chronic
serum sickness in rabbits [8, 9]. It is possible that they
were overlooked; alternatively, the use of multiple in-
jections each day, in contrast with the administration
of a single daily injection given in previous experi-
ments, may have resulted in the formation of larger
amounts of complexes or of different kinds of 'com-
plexes with a propensity to localize or form in extra-
glomerular sites.
2. Human diseases. Although deposits of immuno-
globulins and complement along tubular basement
membranes had not previously been described in
human material, after becoming alerted to them in ex-
perimental models, we soon found several examples in
man. Some of these cases have been reported [10];
since then we have seen a moderate number of addi-
tional patients with such lesions. In the majority there
has been associated glomerular disease, most often
lupus glomerulonephritis. In fact, it appears that in
nearly one-half of patients with lupus nephritis, tubu-
lar or interstitial deposits are present [11]. By immuno-
fluorescence the deposits appear to be focal granular
accumulations of IgG and C3 (Fig. 10) either in the
interstitium, along tubular basement membranes (ap-
parently mainly proximal tubules) or in the walls of
peritubular capillaries (Fig. 12, inset). The deposits
have been shown to react with fluorescein-conjugated
antibody to thymidine (Fig. 11, inset) and cytidine,
indicating that DNA is a constituent of the deposits,
almost certainly representing antigen in immune com-
plexes [12]. Inmost patients with tubular basement de-
Fig. 1. Immunoglobulin deposits along the tubular membrane of a rabbit injected with a preparation of homologous kidney in Freund's
adjuvant (x 250).
Fig. 2. Granular deposits of IgG along the tubular basement membrane in a rabbit with chronic serum sickness nephritis (x 400).
Fig. 3. Granular deposits of BSA along tubular basement membranes in a rabbit with chronic serum sickness nephritis (x 400).
Fig. 4. Granular deposits (arrows) in the walls of peritubular capillaries (C) and along tubular basement membranes in a rabbit with
chronic serum sickness nephritis (toluidine blue, x 800).
Fig. 5. The picture shows plasma cells, polymorphonuclear leukocytes and mononuclear cells in the renal interstitium of a rabbit with
chronic serum sickness nephritis (toluidine blue, x 800). The arrows indicate deposits in the walls of interstitial vessels (V).
Fig. 6. Chronic serum sickness nephritis in a rabbit (x 14,000). The picture illustrates, at higher magnification, an area contiguous to
that enclosed in the boxed area of Fig. 7. There is "splitting" of the tubular basement membrane (arrows). D=electron-opaque
deposits, P= part of the cytoplasm of a plasma cell and T = cytoplasm of the tubule.
Fig. 7. Interstitial nephritis in a rabbit with chronic serum sickness. (x 10,000). Electron-opaque deposits (D) are present on the interstitial
side of tubular basement membrane (arrows) and along the basement membrane of a peritubular vessel (C). M = mononuclear cell,
T= tubular cell and P= part of the cytoplasm cell which has penetrated between the tubular cells.
Fig. 8. The picture shows electron-opaque deposits (arrow heads) along the basement membranes of the tubules (T) of the peritubular capillary
(C) in a rabbit with chronic serum sickness nephritis ( x 10,000). One of the deposits (arrow) is seen on the epithelial side of the tubular
basement membrane. M = pseudopodium of a macrophage which seems to be disrupting the basement membrane of the capillary
(asterisks). The inset shows granular deposits of BSA in the peritubular capillaries of the same jabbit (x 400).
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Fig. 9. Infiltrates of polymorphonuclear leukocytes and mononuclear cells in the interstitium of a patient with active lupus nephritis
(hematoxylin-eosin, x 400).
Fig. 10. Granular deposits of IgG in the interstitium (I) and along the tubules (T) in a patient with active lupus nephritis (x 600).
Fig. 11. Electron-opaque deposits (D) along the tubular basement membrane (arrows) of a distal convoluted tubule (T) of a patient with
lupus nephritis (x 10,000). The inset shows an immunofluorescence preparation with granular deposits in the interstitium and along tubular
basement membranes in a patient with lupus nephritis (x 500). The section was stained with fluorescinated antibody to thymidine.
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Fig. 12. Electron-opaque deposits (D) in the wall of a peritubular capillary (C) and along tubular basement membranes (arrows), in
patient with active lupus nephritis (x 12,000). The inset shows deposits of IgG in the walls of peritubular capillaries in the same patie
(x500).
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posits, there is conspicuous interstitial fibrosis and
inflammation (Fig. 9), as well as tubular cell damage,
suggesting they are of pathogenetic significance. Elec-
tron microscopic examination often shows focal dense
deposits within or along tubular (Fig. 11) or capillary
(Fig. 12) basement membranes. The immunofluor-
escence findings alone are sometimes difficult to evalu-
ate, since deposits cannot always be distinguished from
material in peritubular capillaries; less commonly they
may be confused with reabsorption droplets. Although
their nature can usually be clarified by electron
microscopy, sampling problems make this technique
impractical for routine use.
Aside from being found in lupus nephritis, tubular
deposits have been seen, although much less frequently,
in various other forms of glomerulonephritis, and not
uncommonly in renal allografts [13]. In addition,
similar deposits have been seen in a few patients with
otherwise unexplained tubular and interstitial disease.
The functional importance of these tubular deposits
and the associated tubular and interstitial lesions re-
main to be evaluated. However, several patients have
been found to have glucosuria with normal blood sugar
concentrations. Probably the greatest interest will be
directed at those patients in whom there is no associ-
ated glomerular disease and, in particular, in seeing
whether such cases ever terminate in renal insufficiency.
However, even when seen in association with glomer-
ular disease, it seems highly probable that the tubular
deposits and associated tubular and interstitial changes
may be partially responsible for renal functional im-
pairment. In fact, in a few patients with systemic lupus
erythematosus (SLE), progressive renal failure has
been seen in the presence of tubular and interstitial
lesions with only mild glomerular damage.
Although some of the deposits seen in man closely
resemble those seen in the experimental models, addi-
tional evidence that they are, in fact, immune com-
plexes has been obtained only in patients with lupus
nephritis where antigen (DNA) has been demonstrated
in deposits by immunofluorescence.
In some cases, accumulation of C3 without associ-
ated immunoglobulins is found along tubular base-
ment membranes; the significance of this finding is
difficult to evaluate. Broad, irregular deposits of C3
are often seen along proximal tubular basement mem-
branes in normal rat kidneys, and are occasionally
seen in human kidneys without other compelling evi-
dence of renal disease. One condition in which accumu-
lation of C3 is frequently found without associated
immunoglobulins is the so-called dense deposit disease
(DDD). C3 is found not only along tubular basement
membranes (Fig. 14), but along glomerular basement
membranes and Bowman's capsule as well. The elec-
tron microscopic appearance is distinctive; accumula-
tion of very dense material is found within and along
tubular (Fig. 13) and glomerular basement membranes
in the form of elongated, ribbon-like deposits. The
histologic appearance is often similar to that of mem-
branoproliferative glomerulonephritis (MPGN). How-
ever, mesangial cell proliferation is usually less con-
spicuous than in MPGN and "splitting" of peripheral
glomerular basement membranes, which is a charac-
teristic feature of MPGN, is not found in DDD.
Furthermore, electron microscopy reveals subendothe-
hal deposits in MPGN, in contrast with the predomin-
antly intramembranous deposits in DDD. In addition,
tubular deposits are characteristic of DDD, but are
rarely if ever found in MPGN. It seems likely, there-
fore, that despite similarities in histologic features and
clinical manifestations, MPGN and DDD are separate
conditions. Nevertheless, in most reported studies of
MPGN (or mesangiocapillary glomerulonephritis), it
appears that some cases of DDD are included.
The pathogenesis of the renal lesions in MPGN or
DDD is unknown. In recent years there has been con-
siderable speculation about the role of the complement
system in these disorders, especially concerning the
possibility that alternate pathway activation plays a
central role [141. However, several observations sug-
gest that MPGN has an immune complex pathogenesis.
For one thing, MPGN is characterized by electron-
dense deposits in subendothehial and mesangial re-
gions, which are features of certain established im-
mune complex diseases. Further, the deposits contain
not only C3 and properdin, but also often C1q and
immunoglobulins, findings that are consistent with
activation of the classical as well as the alternate path-
way. In contrast, there is little evidence for a role of
immune complexes in DDD. Thus, immunoglobulins
and C1q are usually absent. Furthermore, there is no
experimental model of immune complex disease that
bears any striking resemblance to DDD. In fact, the
distribution of the deposits is more suggestive of an
effect of autoantibodies directed against GBM and
TBM. At present, the deposits in DDD must be re-
garded as of unknown nature and cause, although the
possibility. that they result from antigen-antibody in-
teraction cannot be said to have been disproved.
B. Antitubular basement membrane antibody disease
(anti-TBM disease). 1. Experimental models. The first
model of experimentally induced antitubular basement
membrane antibody (anti-TBM) disease was described
by Steblay and Rudofsky [15, 16], who reported that
guinea pigs injected with crude rabbit tubular basement
membrane preparations in Freund's adjuvant develop
severe renal disease, characterized by linear deposits of
IgG along tubular basement membranes, with tubular
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cell damage and interstitial accumulation of mono-
nuclear and giant cells (Figs. 13 inset, 15 and 16).
Similar results have been obtained by immunization of
guinea pigs with bovine tubular basement membrane
preparations [17] (Van Zwieten T, Unanue E, Mc-
Cluskey RT, Bhan AK: Unpublished observations).
The disease seems to be mediated by autoantibodies
specific for tubular basement membrane, since passive
transfer of serum results in accumulation of immuno-
globulins along tubular basement membranes and in
lesions in the interstitium in actively immunized ani-
mals [16] (Van Zweiten et al: Unpublished observa-
tions).
Predominantly mononuclear cell infiltrates are un-
usual in antibody-mediated lesions, and where such
infiltrates have been observed, they have been pre-
ceded by a phase in which neutrophils predominate.
Such a phase might easily be missed in actively im-
munized guinea pigs developing anti-TBM disease.
However, even careful study of guinea pigs at early in-
tervals after transfer of anti-TBM antibodies has failed
to reveal an early influx of neutrophils (Van Zweiten
et a!: Unpublished observations). (In rats neutrophils
are sometimes conspicuous early in the course of anti-
TBM disease; see following.) The identity of the infil-
trating mononuclear cells has not been established,
although in histologic sections most of them appear to
be monocytes and some appear to be lymphocytes.
These features suggest a cell-mediated component;
however, as already noted, transfer of serum results in
lesions similar to those in actively immunized donors;
furthermore, attempts to transfer disease with lymph-
node cells in strain 13 guinea pigs have been unsuccess-
ful (Van Zweiten et al: Unpublished observations).
A pathogenetic role for complement is suggested by
the fact that C3 is usually found in assocation with IgG
along tubular basement membranes [17] (Van Zwieten
et al: Unpublished observations). However, Rudofsky
et al found that C4 deficient guinea pigs developed
tubular and interstitial disease which was indistinguish-
able from that produced in normal guinea pigs [18].
These findings do not exclude a role of the complement
system activated via the alternate pathway, and in-
direct evidence for such a role was obtained by
Rudofsky, Steblay and Pollara, who showed that trans-
fer of anti-TBM antibodies to guinea pigs that had
been depleted of complement with cobra venom factor
did not result in lesions [19]. However, tubular and
interstitial abnormalities have been described in guinea
pigs without detectable accumulation of C3, indicating
that complement-independent mechanisms of tissue
damage also operate [15, 17].
The range of reactivity of the antibodies to basement
membranes produced by guinea pigs immunized with
bovine tubular basement membranes preparations has
been studied by Lehman et a! [17]. Direct immuno-
fluorescence showed linear deposits of IgG along tubu-
lar basement membranes (both proximal and distal), of
all guinea pigs studied. In contrast, accumulation of
IgG along glomerular basement membranes was seen
in only 5O% of the animals. However, studies of IgG
eluted from renal tissue always revealed antibodies
against both tubular and glomerular basement mem-
branes, although anti-GBM activity was usually not
detectable when low concentrations of eluted IgG were
used.' Absorption studies of eluates from renal tissue
showed that about three-fourths of the IgG reacted
with bovine basement membrane preparations; all of
the reactive antibody combined with tubular basement
membranes, whereas only 4O% cross-reacted with
glomerular basement membranes. These results in-
dicate that tubular basement membranes have some
antigens that are shared with, as well as some that are
distinct from, those in glomerular basement mem-
branes. There was no evidence for the formation of
antibodies capable of reacting with basement mem-
branes or other structures outside of the kidney
(choroid plexus, heart, lung, liver, spleen, cartilage or
skin).
Another model of anti-TBM disease has been de-
scribed in Brown Norway or Lewis X Brown Norway
'In recent studies (Van Zweiten et al: Unpublished observations)
we have found that after transfer of serum from guinea pigs with
actively induced disease to normal recipients, there was an early
phase during which there was brighter staining for IgG along the
glomerular basement membrane than along the tubular base-
ment membrane, followed by a phase where the reverse was seen.
This sequence suggests that although the antibodies have greater
affinity for tubular basement membranes than glomerular base-
ment membranes, the opportunity to combine with the glomeru-
lar basement membrane in vivo is greater, probably because of
the filtration function of the glomerulus.
Fig. 13. Electron-opaque deposits (D) along the basement membrane of a proximal tubule in a patient with "dense deposit disease"
(x 12,000). The inset shows some aspects of anti-TBM disease in guinea pig (silver methenamine, x 500). One tubule (T) is surrounded
and partially destroyed by a giant cell (G). Only a small portion of its basement membrane is still visible (arrow); in contrast, the base-
ment membrane of another tubule (T1) is evident (arrow heads).
Fig. 14. Deposits of C3 along the tubular basement membranes in a patient with "dense deposit disease" (x 500).
Fig. 15. Anti-TBM disease in guinea pig (hematoxylin-eosin, x 400). The arrows indicate giant cells.
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Fig. 16. Anti-TBM disease in guinea pig (x 100,000). A giant cell (G) is in contact with a proximal tubule (T). The cytoplasm of the
giant cell shows an area of homogenization (asterisk). Only interrupted stretches of tubular basement membrane (arrows) are still vis-
ible. The inset illustrates linear deposits of IgG in tubular basement membranes of the same guinea pig (x 500).
Figs. 17—22 are from Brown-Norway rats immunized with preparations of renal tissue, as described by Sugisaki et al [21].
Fig. 17. Severe infiltration of cells, including giant cells (arrows), in the renal interstitium (hematoxylin-eosin, x 300). There is severe tubu-
lar atrophy, but the glomeruli appear normal.
Fig. 18. Higher magnification of an area of interstitial infiltration, showing a giant cell (hematoxylin-eosin, x 600).
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rats [20]. The rats were injected with suspensions of
Sprague-Dawley rat kidney in complete Freund's ad-
juvant, and also received an injection of pertussis vac-
cine. Within two to three weeks, linear accumulation of
IgG and C3 was seen along the basement membranes
of proximal tubules (Fig. 19). At about this time inter-
stitial accumulation of mononuclear cells and neutro-
phils appeared. Somewhat later (9 to 11 weeks) inter-
stitial multinuclear giant cells became conspicuous
(Figs. 17 and 18). Still later, the histologic picture was
that of severe interstitial inflammation and fibrosis,
and tubular cell damage. Electron microscopic studies
(Figs. 20 through 22) showed tubular cell damage and
injury to tubular basement membranes, including focal
disruption. However, dense deposits, of the type seen
in immune complex tubular disease, were not found.
The multinuclear cells appeared to represent fused
macrophages that had ingested fragments of basement
membrane material.
Several weeks after the onset of tubular and inter-
stitial disease, the characteristic findings of autologous
immune complex glomerular disease generally ap-
peared, with granular deposits of immunoglobulins
and complement along capillary walls.
The evidence supporting a primary pathogenetic role
of anti-TBM antibodies in this model is similar to that
obtained in the guinea pig disease and consists of the
following 1) linear staining for IgG and C3 along
tubular basement membranes; 2) the presence of anti-
bodies in the serum and in eluates of renal tissue that
react in vitro with tubular basement membrane of nor-
mal rat kidney (but not with glomerular basement
membrane); 3) the demonstration that transfer of
serum from rats with actively induced disease to nor-
mal recipients results in typical linear accumulation of
IgG and C3 along tubular basement membranes, as
well as in mild interstitial inflammation. As in the
guinea pig model, the mononuclear cell character of
the infiltrate suggests the possibility of an associated
cell-mediated component: however, again, further evi-
dence for this mechanism remains to be obtained.
Another form of anti-TBM disease has been de-
veloped in certain strains of rats immunized with heter-
ologous (bovine) tubular basement membrane prepara-
tions [21]. This model has the advantage of apparently
not being complicated by autologous immune complex
glomerular disease, thus facilitating studies of tubular
function. The disease was found to develop much more
rapidly and to be more severe in rats immunized with
tubular basement membrane preparations in pertussis
adjuvant than in complete Freund's adjuvant. Two
weeks after immunization of Brown Norway or Lewis
X Brown Norway F1 hybrid rats, there was peritubular
accumulation of neutrophils followed by infiltration of
mononuclear cells, with tubular atrophy and intersti-
tial fibrosis. Linear deposits of IgG were present in the
basement membranes of proximal convoluted tubules,
in 10 to 20% of distal tubules and occasionally along
Bowman's capsule as well. Anti-TBM antibody was
present in the sera and kidney eluates, whereas anti-
GBM antibody was not detectable.
Other strains of rats, similarly immunized, did not
develop interstitial nephritis. Thus, although Lewis,
Wistar-Furth and Maxx rats developed antibodies
against bovine tubular basement membranes, the anti-
bodies did not react with their own tubular basement
membranes and no lesions were seen. Ad, Buffalo,
Wistar-Furth and DA strains had only minimal quanti-
ties of anti-TBM antibodies deposited in their kidneys
and did not develop nephritis.
Another method of inducing the formation of anti-
TBM antibodies is by renal allograft implantation. In
one experiment Lewis X Fisher 344 F1 hybrid kidneys
were transplanted into Lewis rats (Andres GA, Cerra
F, Klassen J, Kano K, Milgrom E: Unpublished ob-
servations). This combination is characterized by iden-
tity for the major ag-B locus and disparity for other,
"weak", histocompatibility loci. Accordingly, the
grafts were not rejected early. However, one to three
months after transplantation, linear deposits of IgG
and C3 were observed in basement membranes of prox-
imal convoluted tubules in about 30% of the grafts.
These deposits were associated with tubular atrophy
and interstitial fibrosis.
A study of the way in which allografts induce anti-
TBM antibody formation was carried out by Lehman
et al [22]. In these experiments, Lewis rats receiving
Lewis X Brown Norway F1 hybrid kidneys developed
interstitial nephritis, with linear accumulation of IgG
and C3 along the basement membranes of proximal
convoluted tubules. Immunoglobulins were not found
in the recipients' own kidneys. (This parallels and also
differs from certain observations in man; see follow-
ing.) In contrast with Lewis rats, Brown Norway rats
receiving Lewis X Brown Norway F1 hybrid kidneys
did not develop anti-TBM antibodies. These findings
indicate that the antibodies were produced only when
a foreign tubular basement membrane antigen was in-
troduced through transplantation, and were not stimu-
lated by the rejection process alone.
The pathogenetic significance of anti-TBM anti-
bodies in grafts is difficult to evaluate, since the rejection
process by itself can produce tubular and interstitial
damage; however, it is reasonable to assume that anti-
TBM antibodies contribute to the damage. Support for
this conclusion has been obtained in another study in
which rat renal allograft recipients developed tubular
and interstitial lesions associated with anti-TBM anti-
282 Andres/McCluskey
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bodies, despite the fact that the rejection mechanism
had been suppressed by i.v. injections by hyperimmune
antidonor serum [23].
II. Human diseases. There is conclusive evidence
that anti-IBM disease occurs in man, although prob-
ably only very uncommonly. One situation is which
anti-TBM antibodies have been documented is in
association with anti-GBM disease, namely in some
patients with Goodpasture's syndrome or rapidly pro-
gressive glomerulonephritis [24]. The presence of anti-
IBM antibodies is indicated by linear accumulation of
IgG and C3 along tubular basement membranes (in
addition to being present along glomerular membranes
[24] (Fig. 24). Moreover, eluates of renal tissue were
shown to contain antibodies which react both with
glomerular and TBM (and with pulmonary basement
membranes as well) [24]. These findings indicate that
the autoantibodies are directed against shared anti-
genic determinants within tubular and glomerular
basement membranes.
It is difficult to assess the importance of anti-TBM
antibodies in patients with anti-GBM disease, since the
glomerular disease itself generally appears severe
enough to account for renal functional impairment;
however, many such patients have severe tubular and
interstitial disease, with accumulation of mononuclear
and sometimes with multinuclear cells (Fig. 23 and 23
inset) indicating that the anti-TBM antibodies are of
importance.
Another situation in which anti-TBM antibodies
have been described is in patients with renal allografts.
The first report [25] described two patients with
chronic glomerulonephritis who received renal allo-
grafts, both of whom developed progressive renal func-
tion of impairment (at about 3 and 14 months). The
damage in the grafts appeared to result both from re-
jection mechanisms, which were evidenced by trans-
plantation antibodies to the graft and by certain mor-
phologic findings, and to anti-IBM antibodies. Thus
linear accumulation of IgG (Fig. 25) and C3 was found
along tubular basement membranes in the allografts,
associated with tubular damage and interstitial mono-
nuclear cell infiltration. In one patient, who had not
been nephrectomized prior to transplantation, similar
staining for IgG was present in the patient's own kid-
neys, showing that the anti-IBM antibodies were
autoantibodies. In addition, indirect immunofluores-
cence and passive transfer studies demonstrated that
immunoglobulins eluted from the grafts reacted with
tubular basement membranes in all human and mon-
key kidneys tested. It was suggested that chronic re-
jection acted as a nonspecific adjuvant, or injured
tubular basement membranes so as to render them
immunogenic.
In a subsequent study [26], a renal transplant recip-
ient was found to have developed antibodies reactive
with the tubular basement membranes, but not with
the glomerular basement membranes, of two successive
renal allografts. Eluted antibody reacted with the
tubular basement membranes of all human kidneys
studied, except the patient's own kidney, and differed
in this respect from the patient described above [25]. It
was proposed that the patient may have reacted to a
foreign tubular basement membrane antigen present in
the allograft but not in his own kidney, as was ob-
served in experiments in rats given allografts [22]. This
interpretation was supported by the demonstration
that the tubular basement membranes of the patient's
kidney had maintained their antigenicity, since they re-
acted with other antihuman-TBM antibodies.
In the past several years, scattered reports have ap-
peared of patients with anti-IBM antibodies and
tubular-interstitial disease, several of which have been
associated with what appears to be immune complex
glomerular disease. Thus, Morel-Maroger et al have
described the development of anti-TBM disease in
association with poststreptococcal glomerulonephritis
[27]. The patient presented with unusually severe post-
streptococcal glomerulonephritis, with the formation
of extensive crescents and later with the development
of tubular cell damage and interstitial inflammation.
In a specimen from an early biopsy, granular deposits
of IgG and C3 were found in glomeruli, but no tubular
staining was present. A later biopsy specimen (28
weeks) showed diffuse linear staining along the tubular
basement membranes, and circulating anti-TBM anti-
bodies were found at this time.
A child with similar findings has been studied by
Fig. 19. Linear accumulation of IgG along tubular basement membranes (x 350). The glomerulus (G) is not stained.
Fig. 20. Electron micrograph showing the result of treatment of a fragment of renal tissue with ferritin-conjugated antibody to rat IgG
(x 30,000). Ferritin granules are localized in the tubular basement membrane (B). The inset illustrates, at lower magnification (x 2,000),
the area from which picture No. 20 was obtained. T = the tubular cytoplasm, I = the interstitium and C = theperitubular capillaries. The
type of fixation and handling of the tissue necessary for preservation of antigenicity and permeability to ferritin-conjugated antibody
account for the presence of artifects in these electron micrographs.
Fig. 21. Irregular thickening of a tubular basement membrane (B) on the epithelial side of the lamina densa (arrows). The interstitium (1)
contains fragments of a macrophage (M).
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Tung, (personal communication). The patient devel-
oped a biopsy-proven acute glomerulonephritis with
features typical of immune complex glomerular
disease; in addition, linear deposits of IgG and C3 were
present in the basement membranes of proximal con-
voluted tubules, and anti-TBM antibodies were found
in the circulation. Twelve months after the beginning
of nephritis, glucosuria and aminoaciduria (Fanconi's
syndrome) have become apparent. Levy, Gagadoux
and Habib [28] have described a 3-yr-old boy with
heavy proteinuria and the Fanconi syndrome. A renal
biopsy specimen revealed typical membranous glomer-
ulonephritis with granular deposits of IgG and C3
along glomerular capillary walls. In addition, there was
linear accumulation of IgG and C3 along tubular base-
ment membranes, and anti-TBM antibodies were dem-
onstrated in the circulation. The presence of intersti-
tial fibrosis, mononuclear cell infiltration and tubular
cell damage (also revealed by the functional studies)
indicates that the anti-TBM antibodies did play a
pathogenetic role.
Another instance of the association of anti-TBM
disease and glomerular disease, apparently of immune
complex pathogenesis, has been described by Harner
et a! [29].
The explanation for the association of immune com-
plex glomerular disease and anti-TBM antibodies is
not clear. One possibility is that the glomerular disease,
which at least in the case reported by Morel-Maroger
clearly preceded the anti-TBM disease, somehow
brought about secondary tubular damage, which in
turn triggered an autoimmune response. Even if this is
so, the anti-TBM antibodies could contribute to the
progression of the disease. It is also possible in some
cases that the disease initially affects tubules through
anti-TBM antibodies and that this sets off an autolo-
gous immune complex glomerular disease, analogous
to the Heymann model.
Of considerable interest is a patient with well docu-
mented anti-TBM disease without associated glomer-
ular disease [30}. The patient was a 6-yr-old boy with
renal glucosuria azotomia and generalized amino-
aciduria. A renal biopsy specimen revealed chronic in-
terstitial nephritis with severe tubular damage. Linear
staining for IgG and C3 was found along tubular base-
ment membranes, and circulating anti-TBM antibodies
were found. No anti-GBM antibodies were demon-
strable.
Recently, anti-TBM antibodies have been detected in
the serum of a patient with methicillin-associated in-
terstitial nephritis [31]. A methicillin-derived antigen,
assumed to be dimethoxyphenylpenicilloyl, as well as
IgG and C3 were bound to the tubular basement mem-
branes. Circulating antibodies were found that reacted
with tubular basement membranes of normal human
and monkey kidneys. It was suggested that the dimeth-
oxyphenyl-penicilloyl haptenic group, which is largely
secreted by the proximal tubules, may bind to the
tubular basement membranes. This might result in the
formation of an immunogenic methicillin-tubular
basement membrane conjugate, which can stimulate
formation of antibodies responsible for the disease. It
is also possible, however, that anti-TBM antibody for-
mation is stimulated by tubular damage initiated in
some other way, possibly involving cell-mediated me-
chanisms, and that the antibodies play at most a
secondary pathogenetic role.
In addition to these fairly well documented examples
of anti-TBM disease, we have seen linear staining for
IgG and C3 along tubular basement membranes in
several renal biopsy specimens in patients without
clear-cut evidence of glomerular disease but with inter-
stitial fibrosis and tubular disease; however, circulat-
ing anti-TBM antibodies were not demonstrable in
these patients and we did not have sufficient renal
tissue with which to perform elution studies, so that
final proof is lacking.
In summary, although lesions mediated by anti-
TBM antibodies have definitely been shown to occur in
man, it seems clear that this type of process is quite
rare. Nevertheless, continued search for anti-TBM
disease appears warranted, since the immunofluores-
cence findings may have been overlooked or misinter-
preted; moreover, in late stages immunoglobulins and
complement may disappear, leaving only damaged
tubules with thickened and abnormal basement mem-
branes.
C. Cytotoxic damage to tubular cells. In rats with
Heymann's nephritis, it appears that autoantibodies
may bind to. antigens of the brush border of the proxi-
mal convoluted tubules in vivo (Fig. 26), thereby pos-
sibly producing complement-mediated cytotoxic dam-
Fig. 22. Macrophages (M) with phagocytosed fragments of basement
indicate pseudopodia of the macrophages.
membrane (X) of a damaged tubule (T) (x 18,000). The arrows
Fig. 23. Interstitial nephritis in anti-GBM-anti-TBM disease in man (hematoxylin-eosin, x 250). The arrow indicates a giant cell and G
part of a glomerulus. The inset shows two giant cells in the interstitium of the same patient (hematoxylin-eosin, x 500).
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age [32]. The cells show loss of microvilli, increased
clasmatosis and accumulation of fragments of epithe-
hal cells in the lumina of the tubules. For such damage
to occur, the antibodies would have to be directed
against material present on the cell surface. No human
counterpart for these lesions has been established.
Antibodies reacting with the cytoplasm of the lining
cells of the Henle's loop have been shown in the sera of
a few patients with glomerulonephritis, or with other
diseases considered to have an immune pathogenesis
[33, 34]. One such patient developed renal tubular
acidosis [35]. However, a pathogenetic role of the
Fig. 24. Linear deposits of IgG in tubular basement membranes of the kidney illustrated in Fig, 23 (x 500).
Fig. 25. Linear deposits of IgG in tubular basement membranes of a human renal allografi (x 500).
Fig. 26. Binding of autoantibodies to the brush border of proximal convoluted tubule in a Brown Norway rat immunized with homologous
kidney suspension (x 600).
Fig. 27. Section of kidney from a Lewis rat immunized with kidney preparation in adjuvant plus pertussis vaccine ten days earlier (x 500).
Severe interstitial infiltration of mononuclear cells is seen.
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antibodies seems unlikely, since most autoantibodies
against intracellular constituents are incapable of
damaging cells in vivo.
II. Cell-mediated tubular and interstitial renal
diseases. The evidence that cell-mediated mechanisms
can account for some forms of interstitial nephritis is
compelling, if not conclusive. In some instances, the
reactivity appears to be directed against autologous
antigens, in others against exogenous material.
A. Autologous antigens. 1. Experimental model. The
possibility that delayed sensitivity against autologous
antigens can produce interstitial nephritis is supported
by the observation that animals injected with homo-
logous or heterologous kidney preparations sometimes
develop renal interstitial mononuclear cell infiltration
(in addition to other lesions) especially shortly after
immunization (Sugisaki T, Klassen J, Andres GA,
McCluskey RT: Unpublished observations) (Fig. 27).
Although the histologic appearance is consistent with
a cell-mediated reaction, it can hardly be considered
proof, especially since it appears that even certain
antibody-dependent processes may at some stages be
characterized by a predominantly mononuclear cell
infiltrate, as described above in experimental anti-
TBM disease. However, direct evidence that cell-
mediated reactivity against renal antigens develops in
rats immunized with renal preparations has been ob-
tained by Grupe [36], who demonstrated that their
lymphoid cells produce macrophage migration in-
hibitory factor in the presence of renal antigens. In
addition, renal antigens may elicit delayed skin reac-
tions in such animals and provoke blast transforma-
tion of their lymphocytes in vitro [37]. A problem in
the investigation of this type of lesion has been its lack
of reproducibility, and convincing evidence that the
lesions can be transferred with lymphoid cells has not
been obtained.
2. Human diseases. In man there is evidence that
cell-mediated reactivity develops against renal antigens
in some patients with various forms of renal disease.
Thus, Rocklin, Lewis and David [38] have demon-
strated migration inhibition factor production by
lymphocytes from some patients with anti-GBM disease
when their lymphocytes were incubated with prepara-
tions of renal tissue. Mahieu, Dardenne and Bach [39]
made similar observations in patients with focal or
diffuse proliferative glomerular disease, as well as in
some patients with renal vascular disease. The possibility
that this reactivity may have pathogenetic significance
is supported by the finding of interstitial mononuclear
cell infiltration in many patients with these conditions
(although, as already indicated, this could be attribut-
able, at least in part, to anti-TBM antibodies).
B. Exogenous antigens. 1. Experimental models.
There is little information regarding delayed reactions
in the kidney elicited by exogenous antigens. Coe and
Feldman, in a study on delayed sensitivity reactions in
extracutaneous sites in guinea pigs [40], were unable to
obtain reactions by direct intrarenal injections of anti-
gen (ovalbumin). They were, however, able to produce
reactions in the urinary bladder; in animals with low
levels of sensitivity (as measured by the intensity of
skin tests), reactions could be obtained only when
the antigen was administered in aggregated form, pre-
sumably because this retarded the rate of loss of anti-
gen from the site. Recently we have found that reac-
tions with the characteristic histologic appearance of
delayed hypersensitivity can be evoked in the renal
cortex, by injection of heat aggregated bovine gamma-
globulin (BGG) in appropriately sensitized guinea pigs
(Van Zweiten T, Bhan A, McCluskey RT: Unpublished
observations). Soluble BGG was not capable ofproduc-
ing a reaction in the kidney, but, as judged by skin
tests to BGG, the level of sensitivity in these animals
was not high.
It has been suggested that delayed sensitivity plays a
role in certain forms of experimental pyelonephritis,
where mononuclear cell infiltration may persist after
disappearance of living microorganisms. Although
this explanation is plausible, proof is lacking.
2. Human disease. A few observations in man sup-
port the possibility that delayed sensitivity reactions to
exogenous antigens can lead to mononuclear interstitial
renal infiltrates. Conspicuous mononuclear-cell in-
filtrates are often seen in bacterial infections of the kid-
ney. The findings are particularly suggestive of an
important delayed component in renal tuberculosis,
where, in addition to typical granulomatous lesions,
extensive mononuclear cell infiltrates are frequently
seen. Finally, interstitial nephritis in which mononu-
clear cells predominate is characteristic of hypersensi-
tivity reactions to certain drugs, such as methicillin,
and although it is possible that these changes are in
part attributable to anti-TBM antibodies, as men-
tioned above, it may also result from delayed reactivity
to antigenic material localized in the kidney [41].
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